Encapsulated Glioma — Trials

Encapsulated Glioma — Trials · CancerIndex

Clinical trials

Registered studies

328 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 116
Recruiting: 55
Ph III recruiting: 5
Growth YoY: —
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 40.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (51)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03975829	Pediatric Long-Term Follow-up and Rollover Study	active not recruiting	Phase 4	163	Novartis PharmaceuticalsINDUSTRY	19	Aug 27, 2026	clinicaltrials
NCT06625047	Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy	completed	Phase 4	30	Mayo ClinicOTHER	1	Apr 29, 2026	clinicaltrials
NCT04650204